Free shipping on all orders over $ 500

Bimekizumab

Cat. No. M24662

All AbMole products are for research use only, cannot be used for human consumption.

Bimekizumab Structure
Synonym:

Anti-Human IL17A/IL-17F Recombinant Antibody

Size Price Availability Quantity
100ug USD 190 In stock
1mg USD 430 In stock
5mg USD 880 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation.

Chemical Information
CAS Number 1418205-77-2
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Sindhuja Koppu, et al. Hum Vaccin Immunother. Review of bimekizumab in the treatment of psoriasis

[2] Angelo Ruggiero, et al. Psoriasis (Auckl). Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge

[3] Egídio Freitas, et al. Drugs. Bimekizumab for the Treatment of Psoriasis

[4] Kristian Reich, et al. N Engl J Med. Bimekizumab versus Secukinumab in Plaque Psoriasis

[5] Richard B Warren, et al. N Engl J Med. Bimekizumab versus Adalimumab in Plaque Psoriasis

Related IL Receptor/Related Products
Reslizumab

Reslizumab (Sch 55700) is a humanized monoclonal antibody targeting human interleukin 5 (IL-5) for the study of eosinophilic asthma. Reslizumab effectively blocks il-5 function. Reslizumab inhibited IL-5-dependent cell proliferation with an IC50 of about 91.1 pM.

Montelukast sodium

Montelukast sodium selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

VGX-1027

VGX-1027 is an orally active immunomodulator.

Diacerein

Diacerin is an inhibitor of pro-inflammatory cytokine Interleukin-1B (IL-1B) production, prescribed for osteoarthritis and chronic inflammatory arthritis.

SC144

SC144 is the first oral active GP130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, eliminates Stat3 phosphorylation and nuclear translocation, and further inhibits downstream target gene expression. SC144 inhibited signal transduction induced by GP130 ligand. SC144 induces apoptosis of human ovarian cancer cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: Bimekizumab, Anti-Human IL17A/IL-17F Recombinant Antibody supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.